Vacara bridges the preclinical-to-clinical translational gap by providing proprietary humanized knock-in mouse models, end-to-end immunology study services, and specialized research reagents—including disease-relevant HLA-DR alleles, peptides, antibodies, and MHC-II tetramers. By physiologically reconstituting human HLA presentation alongside key T-cell and humoral immune components, Vacara enables biotech and pharmaceutical partners to reliably evaluate therapeutic efficacy, dissect disease mechanisms, and de-risk drug candidates across autoimmune, inflammatory, and immuno-oncology indications.